Abnormal electroencephalographic sleep profiles in major depression: Association with response to cognitive behavior therapy

Archives of General Psychiatry

Volumn 53, Issue 2, 1996, Pages 99-108

  Thase, Michael E ^a   Simons, Anne D ^a,b   Reynolds III, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; DEPRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; NEUROPHYSIOLOGY; PATTERN RECOGNITION; PSYCHOTHERAPY; RECURRENCE RISK; REM SLEEP; SLEEP PATTERN; SLEEP WAKING CYCLE; TREATMENT OUTCOME;

EID: 0030045739     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830020013003     Document Type: Article

References (72)

1. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders, a meta-analysis. Arch Gen Psychiatry. 1992;4.651-668
2. Buysse DJ, Kupfer DJ Sleep disorders in depressive disorders. In: Mann JJ, Kupfer DJ, eds. Biology of Depressive Disorders Part A A Systems Perspective. New York, NY: Plenum Press, 1993:123-154.
3. Thase ME, Kupfer DJ. Current status of EEG sleep in the assessment and treatment of depression. In: Burrows GD, Werry JS, eds. Advances in Human Psychopharmacology. Greenwich, Conn: JAI Press Inc; 1987,4:93-148.
4. Thase ME, Simons AD. The applied use of psychotherapy in the study of the psychobiology of depression. J Psychother Pract Res 1992;172-80.
5. Rush AJ. A phase III study of cognitive therapy of depression. In. Williams JBW, Spitzer RL, eds. Psychotherapy Research: Where Are We and Where Should We Go? New York, NY. Guilford Press; 1984:216-233
6. Simons AD, Thase ME. Biological markers, treatment outcome, and 1 year follow-up of endogenous depression, electroencephalographic sleep studies and cognitive therapy J Consult Clin Psychol. 1992,60.392-401.
7. Simons AD, Gordon J, Monroe SM, Thase ME. Toward an integration of cognitive factors, life events, and sleep EEG in depression: effects on course and outcome of cognitive therapy. J Consult Clin Psychol. In press.
8. Jarrett RB, Rush AJ, Khatami M, Roffwarg HP. Does the pretreatment polysomnogram predict response to cognitive therapy in depression outpatients? a preliminary report. Psychiatry Res. 1990;33:285-299.
9. Corbishley M, Beutler L, Quan S, Bamford C, Meredith K, Scogin F. Rapid eye movement density and latency and dexamethasone suppression as predictors of treatment response in depressed older adults. Curr Ther Res. 1990;47.846-859.
10. Buysse D, Kupfer DJ, Frank E, Monk T, Rittenour A, Ehlers CL Electroencephalographic sleep studies in depressed patients treated with psychotherapy, I: baseline studies in responders and nonresponders. Psychiatry Res. 1992;42-13-26.
11. Thase ME, Reynolds CF III, Frank E, Jennings JR, Nofzinger E, Fasiczka AL, Garamoni GL, Kupfer DJ. Polysomnographic studies of unmedicated depressed men before and after treatment with cognitive behavior therapy. Am J Psychiatry. 1994,151 1615-1621.
12. Thase ME, Simons AD, Reynolds CF III. Psychobiological correlates of poor response to cognitive behavior therapy, Psychopharmacol Bull. 1993;29:293-301.
13. Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J, Oliven ME. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1991;148:997-1008.
14. Shea MT, Pilkonis PA, Beckham E, Collins JF, Elkin I, Sotsky SM, Docherty JP. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program Am J Psychiatry. 1990;147:711-718.
15. Hoberman HM, Lewinsohn PM, Tilson M. Group treatment of depression: individual predictors of outcome J Consult Clin Psychol 1988;56.393-398.
16. Buysse DJ, Kupfer DJ. Diagnostic and research applications of electroencephalographic sleep studies in depression: conceptual and methodological issues J Nerv Ment Dis. 1990;178:405-414.
17. Arana GW, Baldessarinl RJ, Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry. 1985;42:1193-1204.
18. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich RF, Shaw DH. Sleep and treatment prediction in endogenous depression. Am J Psychiatry. 1981;138:429-434
19. Mendlewicz J, Kempenaers C, de Maertelaer V. Sleep EEG and amitriptyline treatment in depressed inpatients. Biol Psychiatry. 1991,30.691-702
20. Thase ME, Simons AD, Cahalane J, McGeary J, Harden T. Severity of depression and response to cognitive behavior therapy. Am J Psychiatry. 1991;148: 784-789.
21. Thase ME, Simons AD, McGeary J, Hughes C, Harden T, Friedman E. Relapse after cognitive behavior therapy of depression potential implications for longer courses of treatment? Am J Psychiatry. 1992,149:1046-1052.
22. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978;35:837-848.
23. Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
24. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35:773-782.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
26. Endicott J, Spitzer RL, Fleiss JL. Cohen J. The Global Assessment Scale: a procedure for measuring the overall severity of psychiatric disturbance Arch Gen Psychiatry. 1976;33:766-771.
27. Rechtschaffen A, Kales AA. A Manual of Standardized Terminology, Techniques, and Scoring for Sleep Stages of Human Subjects. Washington, DC: US Dept of Health, Education, and Welfare; 1968.
28. Thase ME, Reynolds CF III, Jennings JR, Frank E, Howell J, Houck PR, Kupfer DJ Technical note: do nocturnal penile tumescence recordings alter electroencephalographic sleep? Sleep. 1987,10 486-490.
29. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia - Lifetime Version New York: New York State Psychiatric Institute Biometrics Research; 1975.
30. Gillin JC, Duncan W, Pettegrew KD, Frankel BL, Snyder F. Successful separation of depression, normal, and insomniac subjects by EEG sleep data. Arch Gen Psychiatry. 1979,36:85-90.
31. Feinberg M, Gillin JC, Carroll BJ, Greden JF, Zis AP EEG studies of sleep in the diagnosis of depression. Biol Psychiatry. 1982;17:305-316.
32. Thase ME, Kupfer DJ, Ulrich RF. Electroencephalographic sleep in psychotic depression: a valid subtype? Arch Gen Psychiatry. 1986,43:886-893.
33. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, NY: Guilford Press; 1979
34. Shaw BF. Specification of the training and evaluation of cognitive therapists for outcome studies. In: Williams JBW, Spitzer RL, eds. Psychotherapy Research. Where Are We and Where We Should Go? New York, NY- Guilford Press; 1984.173-189.
35. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness treatments. Arch Gen Psychiatry 1989;46:971-982
36. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC. The longitudinal interval follow-up evaluation. Arch Gen Psychiatry. 1987;44:540-548.
37. Frank E, Pnen RF, Jarrett RB, Keller MO, Kupfer DJ, Lavori P, Rush AJ, Weissman MM. Conceptualization and rationale to consensus definitions of terms in major depressive disorder. response, remission, recovery, relapse, and recurrence Arch Gen Psychiatry. 1991;48:851-855
38. Lavori PW Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharmacology. 1992,6:39-63.
39. Kraemer HC, Thiemann S. How Many Subjects? Statistical Power Analysis in Research. Newbury Park, Calif. Sage Publications Inc; 1987.
40. Cox DR, Oakes D. Analysis of Survival Data. London, England. Chapman & Hall; 1984.
41. Simons AD, Murphy GE, Levine JI, Wetzel RD. Cognitive therapy and pharmacotherapy for depression: sustained improvement over 1 year. Arch Gen Psychiatry. 1986,43:43-48.
42. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992;49.802-809.
43. Poland RE, McCracken JT, Lutchmansingh P, Tondo L Relationship between REM sleep latency and nocturnal cortisol concentrations in depressed patients. J Sleep Res 1992,1:54-57
44. Giles DE, Schlesser MA, Rush AJ, Orsulak PJ, Fulton CL, Roffwarg HP. Polysomnographic findings and dexamethasone nonsuppression in depression: a replication and extension. Biol Psychiatry 1987;22-872-882.
45. Mendlewicz J, Kerhofs M, Hoffman G, Linkowski P Dexamethasone suppression test and REM sleep in patients with major depressive disorder Br J Psychiatry. 1984;145:383-388.
46. Feinberg M, Carroll BJ. Biological 'markers' for endogenous depression: effect of age, severity of illness, weight loss, and polarity. Arch Gen Psychiatry. 1984; 41:1080-1085.
47. Robbins DR, Alessi NE, Colfer MV. Treatment of adolescents with major depression, implications of the DST and melancholia clinical subtype J Affect Disord. 1989:1799-104.
48. McKnight DL, Nelson-Gray RO, Barnhiil J Dexamethasone suppression test and response to cognitive therapy and antidepressant medications. Behav Ther 1992;1:99-111.
49. Rubinow DR, Post RM, Savard R, Gold PW. Cortisol hypersecretion and cognitive impairment in depression Arch Gen Psychiatry. 1984;41 279-283.
50. Reus VI. Hormonal medication of the memory disorder in depression. Drug Dev Res. 1985,4.489-500.
51. McEwen BS, Angulo J, Cameron H, Chao HM, Daniels D, Gannon MN, Gould E, Mendelson S, Sakai R, Spencer R, Woolley C Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol Psychiatry. 1992; 31:177-199.
52. Kellner CH, Rubinow DR, Gold PW, Post RM Relationship of cortisol hypersecretion to brain CT scan alterations in depression patients Psychiatry Res. 1983,8:191-197.
53. Jimerson DC, Insel TR, Reus VI, Kopin I. Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry. 1983;40173-176
54. Rosenbaum AH, Maruta T, Sehatzberg AF, Orsulak PJ, Jrang NS, Cole JO, Schildkraut JJ Toward a biochemical classification of depressive disorders, VII: urinary-free cortisol and urinary MHPG in depression. Am J Psychiatry. 1983;140.314-318.
55. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress N Engl J Med. 1988,319: 413-420
56. Nemeroff CB New vistas in neuropeptide research in neuropsychiatry, focus on corticotropin-releasing factor. Neuropsychopharmacology. 1992,6:69-75
57. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration. is CRF a mediator of anxiety or stress response? Brain Res Rev. 1990;15:71-100.
58. Enlers CL, Reed TK, Hennksen SJ. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986,42:467-474.
59. Hartlage S, Alloy LB, Vazquez C, Dykman B. Automatic and effortful processing in depression Psychol Bull 1993,113.247-278.
60. Home JA. Human sleep, sleep loss and behavior implications for the prefrontal cortex and psychiatric disorder. Br J Psychiatry. 1993,162:413-419
61. DeJong JA, Roy A. Relationship of cognitive factors to CSF corticotropin-releasing hormone in depression. Am J Psychiatry. 1990,147:350-352.
62. Sampson JA, Mirin SM, Hauser ST, Fenton BT, Schildkraut JJ. Learned helplessness and urinary MHPG levels in unipolar depression Am J Psychiatry 1992;149:806-809
63. Kramer M. The selective mood regulatory function of dreaming: an update and revision In Moffitt AR, Kramer M, Hoffman RF, eds. The Function of Dreaming. Albany: State University of New York Press, 1993 139-195
64. Nofzinger EA, Schwartz RM, Reynolds CF III, Thase ME, Jennings RJ, Frank E, Fasiczka AL, Garamoni GI, Kupfer DJ. Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive behavior therapy. J Consult Clin Psychol. 1994;62:83-91.
65. Stewart JW, Mercier MA, Quitkin FM, McGrath PJ, Nunes E, Young J, Ocepek-Welikson K, Tricamo E. Demoralization predicts nonresponse to cognitive therapy in depressed outpatients. J Cogn Psychother. 1993;7:105-116
66. Weiss JM. Stress-induced depression: critical neurochemical and electrophysiological changes. In: Madden J, ed. Neurobiology of Learning, Emotion. and Affect. New York, NY: Raven Press, 1991:123-154.
67. Wilner P, Golembiowski K, Klimer V, Muscat R. Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 1991,19:79-84.
68. Thase ME Cognitive-behavioral therapy of severe unipolar depression. In: Grunhaus L, Greden JF, eds. Severe Depressive Disorders. Washington, DC. American Psychiatric Press; 1994:269-296
69. Fennell MJV, Teasdale JD, Jones S, Damle A. Distraction in neurotic and endogenous depression. Psychol Med. 1987;17:441-452.
70. American Psychiatric Association Practice guideline tor major depressive disorder in adults. Am J Psychiatry 193;150(suppl 4).1-26
71. Free ML, Oei TPS. Biological and psychological processes in the treatment and maintenance of depression. Clin Psychol Rev. 1989;9:653-688.
72. Thase ME. Reeducative psychotherapy. In: Gabbard GO, ed Treatments of Psychiatric Disorders: The DSM-IV Edition. Washington. DC American Psychiatric Press, 1995:1169-1204